These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 28736984

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Horvath-Ungerboeck C, Thoday KL, Shaw DJ, van den Broek AH.
    Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis.
    Nishiyama T, Kusakabe M, Imanishi I, Hisano T, Fukamachi T, Taguchi N, Iyori K, Hsiao YH.
    Vet Dermatol; 2023 Dec; 34(6):523-531. PubMed ID: 37485602
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
    Ahlstrom LA, Mason KV, Mills PC.
    J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs.
    Schäfer L, Thom N.
    Vet Dermatol; 2024 Aug; 35(4):408-417. PubMed ID: 38465482
    [Abstract] [Full Text] [Related]

  • 36. Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis.
    de Santiago MS, Arribas JLG, Llamas YM, Becvarova I, Meyer H.
    BMC Vet Res; 2021 Nov 19; 17(1):354. PubMed ID: 34798876
    [Abstract] [Full Text] [Related]

  • 37. Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
    White AG, Santoro D, Ahrens K, Marsella R.
    Vet Immunol Immunopathol; 2018 Mar 19; 197():93-101. PubMed ID: 29475513
    [Abstract] [Full Text] [Related]

  • 38. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
    Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, Martinon OM.
    Vet Dermatol; 2016 Dec 19; 27(6):505-e136. PubMed ID: 27647513
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.